Cambridge, MA, United States of America

Immaculada Silos-Santiago

This inventor holds 2 USPTO granted patents. Top assignees: Millenium Pharmaceuticals, Inc., Millennium Pharmaceuticals Limited. Active years: 2002-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Immaculada Silos-Santiago. Retrieved from https://idiyas.com/inventor/immaculada-silos-santiago

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2002-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Immaculada Silos-Santiago: Pioneering Advances in Human Biochemistry

Introduction

Immaculada Silos-Santiago is an innovative inventor based in Cambridge, MA, renowned for her contributions to biochemistry. With two pioneering patents to her name, she has made significant strides in the fields of phospholipase research and the understanding of human aminopeptidases. Her work promises to enhance diagnostics and treatment methodologies for various disorders.

Latest Patents

Silos-Santiago's latest patents include two groundbreaking innovations. The first patent, numbered 32544, elaborates on a novel human phospholipase C. This invention encompasses isolated nucleic acid molecules that encode unique phospholipase family members. In addition, it includes antisense nucleic acid molecules, recombinant expression vectors, and host cells engineered to express the 32544 components. Notably, the patent also discusses the creation of nonhuman transgenic animals modified with the 32544 gene, along with various proteins and antibodies related to this invention, as well as diagnostic methods utilizing these compositions.

Her second patent pertains to a recently identified human aminopeptidase. This invention not only describes polynucleotides encoding the aminopeptidase but also addresses methods for utilizing the polypeptides and polynucleotides in diagnosing and treating aminopeptidase-related disorders. Additionally, it includes drug-screening methods aimed at discovering agonists and antagonists for therapeutic applications, alongside procedures for producing these essential polypeptides and polynucleotides.

Career Highlights

Throughout her career, Immaculada has been associated with renowned firms, including Millennium Pharmaceuticals and its branch, Millennium Pharmaceuticals Limited. Her experience at these institutions has enriched her knowledge and expertise in the field, allowing her to flourish as a leading inventor in biochemistry.

Collaborations

Immaculada has collaborated with notable professionals in her field, including Rosana Kapeller-Libermann and David W. White. Their collective efforts have contributed to significant advancements in research and development, further propelling the impact of her patent innovations.

Conclusion

Immaculada Silos-Santiago stands as a beacon of innovation in bio-pharmaceutical research. With her two significant patents, she continues to pave the way for advancements in human health diagnostics and treatments. Her dedication and collaborative efforts inspire the next generation of inventors and scientists in the rapidly evolving field of biochemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…